IndraLab

Statements


CYLD inhibits PRKCQ. 2 / 2
| 2

reach
"CYLD Reduces Activation of PKC-theta and Impairs NF-kappaB Activation in CD8 + T Cells."

reach
"Thus, CYLD, which is known to interact with PKC-theta, impaired the activation of PKC-theta and NF-kappaB in CD8 + T cells."